These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24048820)

  • 1. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
    Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
    Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.
    Li J; Risinger AL; Peng J; Chen Z; Hu L; Mooberry SL
    J Am Chem Soc; 2011 Nov; 133(47):19064-7. PubMed ID: 22040100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taccalonolide microtubule stabilizers.
    Li J; Risinger AL; Mooberry SL
    Bioorg Med Chem; 2014 Sep; 22(18):5091-6. PubMed ID: 24491636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ.
    Risinger AL; Li J; Du L; Benavides R; Robles AJ; Cichewicz RH; Kuhn JG; Mooberry SL
    J Nat Prod; 2017 Feb; 80(2):409-414. PubMed ID: 28112516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
    Risinger AL; Mooberry SL
    Cell Cycle; 2011 Jul; 10(13):2162-71. PubMed ID: 21597323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.
    Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL
    Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taccalonolide Microtubule Stabilizers.
    Yee SS; Du L; Risinger AL
    Prog Chem Org Nat Prod; 2020; 112():183-206. PubMed ID: 33306174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases.
    Rohena CC; Peng J; Johnson TA; Crews P; Mooberry SL
    Biochem Pharmacol; 2013 Apr; 85(8):1104-14. PubMed ID: 23399639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation.
    Risinger AL; Riffle SM; Lopus M; Jordan MA; Wilson L; Mooberry SL
    Mol Cancer; 2014 Feb; 13():41. PubMed ID: 24576146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating target specificity of the taccalonolide covalent microtubule stabilizers employing a combinatorial chemical approach.
    Du L; Yee SS; Ramachandran K; Risinger AL
    Nat Commun; 2020 Jan; 11(1):654. PubMed ID: 32005831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of microtubule stabilization by taccalonolide AJ.
    Wang Y; Yu Y; Li GB; Li SA; Wu C; Gigant B; Qin W; Chen H; Wu Y; Chen Q; Yang J
    Nat Commun; 2017 Jun; 8():15787. PubMed ID: 28585532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taccalonolide C-6 Analogues, Including Paclitaxel Hybrids, Demonstrate Improved Microtubule Polymerizing Activities.
    Risinger AL; Hastings SD; Du L
    J Nat Prod; 2021 Jun; 84(6):1799-1805. PubMed ID: 34110822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
    Buey RM; Calvo E; Barasoain I; Pineda O; Edler MC; Matesanz R; Cerezo G; Vanderwal CD; Day BW; Sorensen EJ; López JA; Andreu JM; Hamel E; Díaz JF
    Nat Chem Biol; 2007 Feb; 3(2):117-25. PubMed ID: 17206139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of C-6 as a New Site for Linker Conjugation to the Taccalonolide Microtubule Stabilizers.
    Du L; Risinger AL; Yee SS; Ola ARB; Zammiello CL; Cichewicz RH; Mooberry SL
    J Nat Prod; 2019 Mar; 82(3):583-588. PubMed ID: 30799622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taccalonolides: A Novel Class of Microtubule-Stabilizing Anticancer Agents.
    Chen X; Winstead A; Yu H; Peng J
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taccalonolides: Novel microtubule stabilizers with clinical potential.
    Risinger AL; Mooberry SL
    Cancer Lett; 2010 May; 291(1):14-9. PubMed ID: 19880245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models.
    Yee SS; Risinger AL
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and biological activities of new taccalonolide microtubule stabilizers.
    Peng J; Risinger AL; Fest GA; Jackson EM; Helms G; Polin LA; Mooberry SL
    J Med Chem; 2011 Sep; 54(17):6117-24. PubMed ID: 21800839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule.
    Sánchez-Murcia PA; Mills A; Cortés-Cabrera Á; Gago F
    J Comput Aided Mol Des; 2019 Jul; 33(7):627-644. PubMed ID: 31152293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.